Showing 501-510 of 868 results for "".
The HRQoL Impact of Psoriasis: Perspectives for Value-Based Reimbursement
https://practicaldermatology.com/topics/psoriasis/the-hrqol-impact-of-psoriasis-perspectives-for-value-based-reimbursement/20932/Understanding the psychological/social burden of psoriasis on patients is critical as new therapeutics position themselves for reimbursement in a crowded and increasingly undifferentiated field.Use of Hylenex to Treat Microstomia in CREST Syndrome: A Case Study and Call to Action
https://practicaldermatology.com/youngmd-connect/resident-resource-center/proton-pump-inhibitor-induced-dermal-hypersensitivity-reaction-masquerading-as-an-arthropod-bite-reaction/23915/Manage and Prevent Isotretinoin Side Effects
https://practicaldermatology.com/topics/general-topics/PD0409_01-php/22839/This guide will help you anticipate and prevent or minimize side effects that your patients can develop as a result of isotretinoin therapy.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-44/23875/The Placebo and Nocebo Effects in Dermatology
https://practicaldermatology.com/columns/clinical-focus-1/the-placebo-and-nocebo-effects-in-dermatology/23559/Increasing evidence suggests that these effects—though not fully understood—may be harnessed for patient care.Dr. Goldberg Discusses Experience with the VariLite Laser
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dr-goldberg-discusses-experience-with-gemini-laser/19468/“One of the great things about being in the laser field is there are new lasers that come out every day. It makes it a very exciting arena to be in. The problem is the popular machine of today, unfortunately, often becomes the machine that you don't need a year from now. The VariLite is tried andAnalyzing Safety Data From Level Up
https://practicaldermatology.com/series/the-practical-dermatology-podcast/analyzing-safety-data-from-level-up/33944/The latest news and updates, plus Matthew Zirwas, MD, FAAD, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to discuss the importance of the Week 16 safety data from the Level Up study on upadacitinib. Silverberg JI, Bunick CG, et al. Efficacy and safety of upadacitinib versuWebsite Rankings of Dermatology Associations; News and Trends
https://practicaldermatology.com/youngmd-connect/resident-resource-center/website-rankings-of-dermatology-associations-news-and-trends/20854/Biologics and Pediatric Psoriasis
https://practicaldermatology.com/topics/practice-management/biologics-and-pediatric-psoriasis/21196/Though data has been lacking in recent years, the use of biologics in pediatric and adolescent patients deserves more consideration.Therapeutics Focus: Skin Cancer
https://practicaldermatology.com/topics/skin-cancer-photoprotection/therapeutics-focus-skin-cancer/21419/New products and pharmacologic developments